The author of the most recent Seeking Alpha article erroneously down plays the value in CD4 gains... The comments in the article itself address this sufficiently.
The big giant grey elephant in the room of his article is... The CD4 gains were all based on ONE infusion.
How many times do I need to repeat that?
If the therapy is safe, how many times do you think a patient is going to take their medicine before they are cured?
Answer - as much as it takes.
So the therapy will require as many infusions as are required to get the patient cured.
He pulls the conclusion from the data that he wants to see rather than understanding what the data means.
I am glad he is short. I will enjoy taking his money.
Thanks for the cheap shares Adam.
Sentiment: Strong Buy